Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Kouklakis

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|June 7, 2007
Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imagingMichael I Koukourakis, Ioannis Mavanis, George Kouklakis, et al.
Romanian Journal of Gastroenterology|January 10, 2006
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case reportGeorge Kouklakis, John Moschos, Grigoris I Leontiadis, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2007
Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's diseaseKonstantinos Vadikolias, George Kouklakis, Ioannis Heliopoulos, et al.
Journal of Medical Case Reports|December 11, 2007
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literatureGeorge Kouklakis, Eleni I Efremidou, Michael S Papageorgiou, et al.
Surgery Today|October 31, 2006
Enterolith small-bowel obstruction caused by jejunal diverticulosis: Report of a caseEleni I Efremidou, Nikolaos Liratzopoulos, Michalis S Papageorgiou, et al.
Scandinavian Journal of Gastroenterology|June 5, 2014
Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational studyAthanasios Zissimopoulos, Stergios Vradelis, Manolis Konialis, et al.
Annals of Gastroenterology|April 10, 2014
Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family supportNikos Viazis, Gerasimos Mantzaris, Konstantinos Karmiris, et al.
Annals of Gastroenterology|October 22, 2014
Patients with established gastro-esophageal reflux disease might benefit from <i>Helicobacter pylori</i> eradicationJohn M Moschos, George Kouklakis, Stergios Vradelis, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 28, 2006
Lateral subcutaneous internal sphincterotomy in the treatment of chronic anal fissure: our experienceNikolaos Liratzopoulos, Eleni I Efremidou, Michael S Papageorgiou, et al.
Case Reports in Gastroenterology|October 12, 2012
Tuberculosis in the peritoneum: not too rare after allMichael Karanikas, Konstantinos Porpodis, Paul Zarogoulidis, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|June 7, 2007
Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imagingMichael I Koukourakis, Ioannis Mavanis, George Kouklakis, et al.
Romanian Journal of Gastroenterology|January 10, 2006
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case reportGeorge Kouklakis, John Moschos, Grigoris I Leontiadis, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2007
Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's diseaseKonstantinos Vadikolias, George Kouklakis, Ioannis Heliopoulos, et al.
Journal of Medical Case Reports|December 11, 2007
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literatureGeorge Kouklakis, Eleni I Efremidou, Michael S Papageorgiou, et al.
Surgery Today|October 31, 2006
Enterolith small-bowel obstruction caused by jejunal diverticulosis: Report of a caseEleni I Efremidou, Nikolaos Liratzopoulos, Michalis S Papageorgiou, et al.
Scandinavian Journal of Gastroenterology|June 5, 2014
Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational studyAthanasios Zissimopoulos, Stergios Vradelis, Manolis Konialis, et al.
Annals of Gastroenterology|April 10, 2014
Inflammatory bowel disease: Greek patients' perspective on quality of life, information on the disease, work productivity and family supportNikos Viazis, Gerasimos Mantzaris, Konstantinos Karmiris, et al.
Annals of Gastroenterology|October 22, 2014
Patients with established gastro-esophageal reflux disease might benefit from <i>Helicobacter pylori</i> eradicationJohn M Moschos, George Kouklakis, Stergios Vradelis, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|June 28, 2006
Lateral subcutaneous internal sphincterotomy in the treatment of chronic anal fissure: our experienceNikolaos Liratzopoulos, Eleni I Efremidou, Michael S Papageorgiou, et al.
Case Reports in Gastroenterology|October 12, 2012
Tuberculosis in the peritoneum: not too rare after allMichael Karanikas, Konstantinos Porpodis, Paul Zarogoulidis, et al.
Pageof 4